COVID 19 Impact on Global Biopharmaceuticals Market Size Status and Forecast 2020 2026

BUY CHAPTERS

Global Biopharmaceuticals Market Research Report 2023

Code: QYRE-Auto-30B2315

Report

January 2023

Pages:115

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Roche

Amgen Inc

AbbVie

Sanofi Aventis

Johnson & Johnson

Pfizer Inc

Novo Nordisk

Eli Lilly

Novartis

Merck

World Health Organization

Sun

3SBio Inc

Changchun High Tech

CP Guojian

Biotech

Gelgen

Innovent

Dong Bao

Ganlee

United Laboratories

Sandoz(Novartis)

Teva Pharmaceutical

Hospira (Pfizer)

Mylan NV

Sun Pharma

A biopharmaceutical, also known as a biologic (al) medical product, biological, or biologic, is any pharmaceutical drug product manufactured in, extracted from, or semi synthesized from biological sources. Different from totally synthesized pharmaceuticals, they include vaccines, blood, blood components, allergenic, somatic cells, gene therapies, tissues, recombinant therapeutic protein, and living cells used in cell therapy. Biologics can be composed of sugars, proteins, or nucleic acids or complex combinations of these substances, or may be living cells or tissues. They (or their precursors or components) are isolated from living sources—human, animal, plant, fungal, or microbial.

Highlights

The global Biopharmaceuticals market was valued at US$ 35210 million in 2022 and is anticipated to reach US$ 55880 million by 2029, witnessing a CAGR of 8.0% during the forecast period 2023-2029.

The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

North American market for Biopharmaceuticals is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

Asia-Pacific market for Biopharmaceuticals is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The global market for Biopharmaceuticals in Tumor is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The key global companies of Biopharmaceuticals include Roche, Amgen, AbbVie, Sanofi-Aventis, Johnson & Johnson, Pfizer, Novo Nordisk, Eli Lilly and Novartis, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Biopharmaceuticals, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biopharmaceuticals.

The Biopharmaceuticals market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Biopharmaceuticals market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Biopharmaceuticals companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

BY COMPANY

Roche

Amgen

AbbVie

Sanofi-Aventis

Johnson & Johnson

Pfizer

Novo Nordisk

Eli Lilly

Novartis

Merck

Sun

3sbio

Changchun High Tech

CP Guojian

Biotech

Gelgen

Innovent

Dong Bao

Ganlee

United Laboratories

SANDOZ (NOVARTIS)

Teva Pharmaceutical

Hospira （Pfizer）

MYLAN

Sun pharma

Segment by Type

Monoclonal Antibodies

Interferon

Colony-Stimulating Factor

Erythropoietin

Insulin

Vaccines

Growth Hormones

Others

Segment by Application

Tumor

Diabetes

Cardiovascular

Hemophilia

Others

BY REGION

North America

United States

Canada

Europe

Germany

France

Italy

Russia

Nordic Countries

Rest of Europe

Asia-Pacific

China

Japan

South Korea

Southeast Asia

India

Australia

Rest of Asia

Latin America

Mexico

Brazil

Rest of Latin America

Middle East & Africa

Turkey

Saudi Arabia

UAE

Rest of MEA

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Biopharmaceuticals companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 12: The main points and conclusions of the report.

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Biopharmaceuticals Market Size Growth Rate by Type: 2018 VS 2022 VS 2029

1.2.2 Monoclonal Antibodies

1.2.3 Interferon

1.2.4 Colony-Stimulating Factor

1.2.5 Erythropoietin

1.2.6 Insulin

1.2.7 Vaccines

1.2.8 Growth Hormones

1.2.9 Others

1.3 Market by Application

1.3.1 Global Biopharmaceuticals Market Growth by Application: 2018 VS 2022 VS 2029

1.3.2 Tumor

1.3.3 Diabetes

1.3.4 Cardiovascular

1.3.5 Hemophilia

1.3.6 Others

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Biopharmaceuticals Market Perspective (2018-2029)

2.2 Biopharmaceuticals Growth Trends by Region

2.2.1 Global Biopharmaceuticals Market Size by Region: 2018 VS 2022 VS 2029

2.2.2 Biopharmaceuticals Historic Market Size by Region (2018-2023)

2.2.3 Biopharmaceuticals Forecasted Market Size by Region (2024-2029)

2.3 Biopharmaceuticals Market Dynamics

2.3.1 Biopharmaceuticals Industry Trends

2.3.2 Biopharmaceuticals Market Drivers

2.3.3 Biopharmaceuticals Market Challenges

2.3.4 Biopharmaceuticals Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Biopharmaceuticals Players by Revenue

3.1.1 Global Top Biopharmaceuticals Players by Revenue (2018-2023)

3.1.2 Global Biopharmaceuticals Revenue Market Share by Players (2018-2023)

3.2 Global Biopharmaceuticals Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Biopharmaceuticals Revenue

3.4 Global Biopharmaceuticals Market Concentration Ratio

3.4.1 Global Biopharmaceuticals Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Biopharmaceuticals Revenue in 2022

3.5 Biopharmaceuticals Key Players Head office and Area Served

3.6 Key Players Biopharmaceuticals Product Solution and Service

3.7 Date of Enter into Biopharmaceuticals Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Biopharmaceuticals Breakdown Data by Type

4.1 Global Biopharmaceuticals Historic Market Size by Type (2018-2023)

4.2 Global Biopharmaceuticals Forecasted Market Size by Type (2024-2029)

5 Biopharmaceuticals Breakdown Data by Application

5.1 Global Biopharmaceuticals Historic Market Size by Application (2018-2023)

5.2 Global Biopharmaceuticals Forecasted Market Size by Application (2024-2029)

6 North America

6.1 North America Biopharmaceuticals Market Size (2018-2029)

6.2 North America Biopharmaceuticals Market Growth Rate by Country: 2018 VS 2022 VS 2029

6.3 North America Biopharmaceuticals Market Size by Country (2018-2023)

6.4 North America Biopharmaceuticals Market Size by Country (2024-2029)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Biopharmaceuticals Market Size (2018-2029)

7.2 Europe Biopharmaceuticals Market Growth Rate by Country: 2018 VS 2022 VS 2029

7.3 Europe Biopharmaceuticals Market Size by Country (2018-2023)

7.4 Europe Biopharmaceuticals Market Size by Country (2024-2029)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Biopharmaceuticals Market Size (2018-2029)

8.2 Asia-Pacific Biopharmaceuticals Market Growth Rate by Region: 2018 VS 2022 VS 2029

8.3 Asia-Pacific Biopharmaceuticals Market Size by Region (2018-2023)

8.4 Asia-Pacific Biopharmaceuticals Market Size by Region (2024-2029)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Biopharmaceuticals Market Size (2018-2029)

9.2 Latin America Biopharmaceuticals Market Growth Rate by Country: 2018 VS 2022 VS 2029

9.3 Latin America Biopharmaceuticals Market Size by Country (2018-2023)

9.4 Latin America Biopharmaceuticals Market Size by Country (2024-2029)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Biopharmaceuticals Market Size (2018-2029)

10.2 Middle East & Africa Biopharmaceuticals Market Growth Rate by Country: 2018 VS 2022 VS 2029

10.3 Middle East & Africa Biopharmaceuticals Market Size by Country (2018-2023)

10.4 Middle East & Africa Biopharmaceuticals Market Size by Country (2024-2029)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Roche

11.1.1 Roche Company Detail

11.1.2 Roche Business Overview

11.1.3 Roche Biopharmaceuticals Introduction

11.1.4 Roche Revenue in Biopharmaceuticals Business (2018-2023)

11.1.5 Roche Recent Development

11.2 Amgen

11.2.1 Amgen Company Detail

11.2.2 Amgen Business Overview

11.2.3 Amgen Biopharmaceuticals Introduction

11.2.4 Amgen Revenue in Biopharmaceuticals Business (2018-2023)

11.2.5 Amgen Recent Development

11.3 AbbVie

11.3.1 AbbVie Company Detail

11.3.2 AbbVie Business Overview

11.3.3 AbbVie Biopharmaceuticals Introduction

11.3.4 AbbVie Revenue in Biopharmaceuticals Business (2018-2023)

11.3.5 AbbVie Recent Development

11.4 Sanofi-Aventis

11.4.1 Sanofi-Aventis Company Detail

11.4.2 Sanofi-Aventis Business Overview

11.4.3 Sanofi-Aventis Biopharmaceuticals Introduction

11.4.4 Sanofi-Aventis Revenue in Biopharmaceuticals Business (2018-2023)

11.4.5 Sanofi-Aventis Recent Development

11.5 Johnson & Johnson

11.5.1 Johnson & Johnson Company Detail

11.5.2 Johnson & Johnson Business Overview

11.5.3 Johnson & Johnson Biopharmaceuticals Introduction

11.5.4 Johnson & Johnson Revenue in Biopharmaceuticals Business (2018-2023)

11.5.5 Johnson & Johnson Recent Development

11.6 Pfizer

11.6.1 Pfizer Company Detail

11.6.2 Pfizer Business Overview

11.6.3 Pfizer Biopharmaceuticals Introduction

11.6.4 Pfizer Revenue in Biopharmaceuticals Business (2018-2023)

11.6.5 Pfizer Recent Development

11.7 Novo Nordisk

11.7.1 Novo Nordisk Company Detail

11.7.2 Novo Nordisk Business Overview

11.7.3 Novo Nordisk Biopharmaceuticals Introduction

11.7.4 Novo Nordisk Revenue in Biopharmaceuticals Business (2018-2023)

11.7.5 Novo Nordisk Recent Development

11.8 Eli Lilly

11.8.1 Eli Lilly Company Detail

11.8.2 Eli Lilly Business Overview

11.8.3 Eli Lilly Biopharmaceuticals Introduction

11.8.4 Eli Lilly Revenue in Biopharmaceuticals Business (2018-2023)

11.8.5 Eli Lilly Recent Development

11.9 Novartis

11.9.1 Novartis Company Detail

11.9.2 Novartis Business Overview

11.9.3 Novartis Biopharmaceuticals Introduction

11.9.4 Novartis Revenue in Biopharmaceuticals Business (2018-2023)

11.9.5 Novartis Recent Development

11.10 Merck

11.10.1 Merck Company Detail

11.10.2 Merck Business Overview

11.10.3 Merck Biopharmaceuticals Introduction

11.10.4 Merck Revenue in Biopharmaceuticals Business (2018-2023)

11.10.5 Merck Recent Development

11.11 Sun

11.11.1 Sun Company Detail

11.11.2 Sun Business Overview

11.11.3 Sun Biopharmaceuticals Introduction

11.11.4 Sun Revenue in Biopharmaceuticals Business (2018-2023)

11.11.5 Sun Recent Development

11.12 3sbio

11.12.1 3sbio Company Detail

11.12.2 3sbio Business Overview

11.12.3 3sbio Biopharmaceuticals Introduction

11.12.4 3sbio Revenue in Biopharmaceuticals Business (2018-2023)

11.12.5 3sbio Recent Development

11.13 Changchun High Tech

11.13.1 Changchun High Tech Company Detail

11.13.2 Changchun High Tech Business Overview

11.13.3 Changchun High Tech Biopharmaceuticals Introduction

11.13.4 Changchun High Tech Revenue in Biopharmaceuticals Business (2018-2023)

11.13.5 Changchun High Tech Recent Development

11.14 CP Guojian

11.14.1 CP Guojian Company Detail

11.14.2 CP Guojian Business Overview

11.14.3 CP Guojian Biopharmaceuticals Introduction

11.14.4 CP Guojian Revenue in Biopharmaceuticals Business (2018-2023)

11.14.5 CP Guojian Recent Development

11.15 Biotech

11.15.1 Biotech Company Detail

11.15.2 Biotech Business Overview

11.15.3 Biotech Biopharmaceuticals Introduction

11.15.4 Biotech Revenue in Biopharmaceuticals Business (2018-2023)

11.15.5 Biotech Recent Development

11.16 Gelgen

11.16.1 Gelgen Company Detail

11.16.2 Gelgen Business Overview

11.16.3 Gelgen Biopharmaceuticals Introduction

11.16.4 Gelgen Revenue in Biopharmaceuticals Business (2018-2023)

11.16.5 Gelgen Recent Development

11.17 Innovent

11.17.1 Innovent Company Detail

11.17.2 Innovent Business Overview

11.17.3 Innovent Biopharmaceuticals Introduction

11.17.4 Innovent Revenue in Biopharmaceuticals Business (2018-2023)

11.17.5 Innovent Recent Development

11.18 Dong Bao

11.18.1 Dong Bao Company Detail

11.18.2 Dong Bao Business Overview

11.18.3 Dong Bao Biopharmaceuticals Introduction

11.18.4 Dong Bao Revenue in Biopharmaceuticals Business (2018-2023)

11.18.5 Dong Bao Recent Development

11.19 Ganlee

11.19.1 Ganlee Company Detail

11.19.2 Ganlee Business Overview

11.19.3 Ganlee Biopharmaceuticals Introduction

11.19.4 Ganlee Revenue in Biopharmaceuticals Business (2018-2023)

11.19.5 Ganlee Recent Development

11.20 United Laboratories

11.20.1 United Laboratories Company Detail

11.20.2 United Laboratories Business Overview

11.20.3 United Laboratories Biopharmaceuticals Introduction

11.20.4 United Laboratories Revenue in Biopharmaceuticals Business (2018-2023)

11.20.5 United Laboratories Recent Development

11.21 SANDOZ (NOVARTIS)

11.21.1 SANDOZ (NOVARTIS) Company Detail

11.21.2 SANDOZ (NOVARTIS) Business Overview

11.21.3 SANDOZ (NOVARTIS) Biopharmaceuticals Introduction

11.21.4 SANDOZ (NOVARTIS) Revenue in Biopharmaceuticals Business (2018-2023)

11.21.5 SANDOZ (NOVARTIS) Recent Development

11.22 Teva Pharmaceutical

11.22.1 Teva Pharmaceutical Company Detail

11.22.2 Teva Pharmaceutical Business Overview

11.22.3 Teva Pharmaceutical Biopharmaceuticals Introduction

11.22.4 Teva Pharmaceutical Revenue in Biopharmaceuticals Business (2018-2023)

11.22.5 Teva Pharmaceutical Recent Development

11.23 Hospira （Pfizer）

11.23.1 Hospira （Pfizer） Company Detail

11.23.2 Hospira （Pfizer） Business Overview

11.23.3 Hospira （Pfizer） Biopharmaceuticals Introduction

11.23.4 Hospira （Pfizer） Revenue in Biopharmaceuticals Business (2018-2023)

11.23.5 Hospira （Pfizer） Recent Development

11.24 MYLAN

11.24.1 MYLAN Company Detail

11.24.2 MYLAN Business Overview

11.24.3 MYLAN Biopharmaceuticals Introduction

11.24.4 MYLAN Revenue in Biopharmaceuticals Business (2018-2023)

11.24.5 MYLAN Recent Development

11.25 Sun pharma

11.25.1 Sun pharma Company Detail

11.25.2 Sun pharma Business Overview

11.25.3 Sun pharma Biopharmaceuticals Introduction

11.25.4 Sun pharma Revenue in Biopharmaceuticals Business (2018-2023)

11.25.5 Sun pharma Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Roche

Amgen Inc

AbbVie

Sanofi Aventis

Johnson & Johnson

Pfizer Inc

Novo Nordisk

Eli Lilly

Novartis

Merck

World Health Organization

Sun

3SBio Inc

Changchun High Tech

CP Guojian

Biotech

Gelgen

Innovent

Dong Bao

Ganlee

United Laboratories

Sandoz(Novartis)

Teva Pharmaceutical

Hospira (Pfizer)

Mylan NV

Sun Pharma

List of Tables

Table 1. Global Biopharmaceuticals Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029

Table 2. Key Players of Monoclonal Antibodies

Table 3. Key Players of Interferon

Table 4. Key Players of Colony-Stimulating Factor

Table 5. Key Players of Erythropoietin

Table 6. Key Players of Insulin

Table 7. Key Players of Vaccines

Table 8. Key Players of Growth Hormones

Table 9. Key Players of Others

Table 10. Global Biopharmaceuticals Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029

Table 11. Global Biopharmaceuticals Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

Table 12. Global Biopharmaceuticals Market Size by Region (2018-2023) & (US$ Million)

Table 13. Global Biopharmaceuticals Market Share by Region (2018-2023)

Table 14. Global Biopharmaceuticals Forecasted Market Size by Region (2024-2029) & (US$ Million)

Table 15. Global Biopharmaceuticals Market Share by Region (2024-2029)

Table 16. Biopharmaceuticals Market Trends

Table 17. Biopharmaceuticals Market Drivers

Table 18. Biopharmaceuticals Market Challenges

Table 19. Biopharmaceuticals Market Restraints

Table 20. Global Biopharmaceuticals Revenue by Players (2018-2023) & (US$ Million)

Table 21. Global Biopharmaceuticals Market Share by Players (2018-2023)

Table 22. Global Top Biopharmaceuticals Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biopharmaceuticals as of 2022)

Table 23. Ranking of Global Top Biopharmaceuticals Companies by Revenue (US$ Million) in 2022

Table 24. Global 5 Largest Players Market Share by Biopharmaceuticals Revenue (CR5 and HHI) & (2018-2023)

Table 25. Key Players Headquarters and Area Served

Table 26. Key Players Biopharmaceuticals Product Solution and Service

Table 27. Date of Enter into Biopharmaceuticals Market

Table 28. Mergers & Acquisitions, Expansion Plans

Table 29. Global Biopharmaceuticals Market Size by Type (2018-2023) & (US$ Million)

Table 30. Global Biopharmaceuticals Revenue Market Share by Type (2018-2023)

Table 31. Global Biopharmaceuticals Forecasted Market Size by Type (2024-2029) & (US$ Million)

Table 32. Global Biopharmaceuticals Revenue Market Share by Type (2024-2029)

Table 33. Global Biopharmaceuticals Market Size by Application (2018-2023) & (US$ Million)

Table 34. Global Biopharmaceuticals Revenue Market Share by Application (2018-2023)

Table 35. Global Biopharmaceuticals Forecasted Market Size by Application (2024-2029) & (US$ Million)

Table 36. Global Biopharmaceuticals Revenue Market Share by Application (2024-2029)

Table 37. North America Biopharmaceuticals Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

Table 38. North America Biopharmaceuticals Market Size by Country (2018-2023) & (US$ Million)

Table 39. North America Biopharmaceuticals Market Size by Country (2024-2029) & (US$ Million)

Table 40. Europe Biopharmaceuticals Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

Table 41. Europe Biopharmaceuticals Market Size by Country (2018-2023) & (US$ Million)

Table 42. Europe Biopharmaceuticals Market Size by Country (2024-2029) & (US$ Million)

Table 43. Asia-Pacific Biopharmaceuticals Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029

Table 44. Asia-Pacific Biopharmaceuticals Market Size by Region (2018-2023) & (US$ Million)

Table 45. Asia-Pacific Biopharmaceuticals Market Size by Region (2024-2029) & (US$ Million)

Table 46. Latin America Biopharmaceuticals Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

Table 47. Latin America Biopharmaceuticals Market Size by Country (2018-2023) & (US$ Million)

Table 48. Latin America Biopharmaceuticals Market Size by Country (2024-2029) & (US$ Million)

Table 49. Middle East & Africa Biopharmaceuticals Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

Table 50. Middle East & Africa Biopharmaceuticals Market Size by Country (2018-2023) & (US$ Million)

Table 51. Middle East & Africa Biopharmaceuticals Market Size by Country (2024-2029) & (US$ Million)

Table 52. Roche Company Detail

Table 53. Roche Business Overview

Table 54. Roche Biopharmaceuticals Product

Table 55. Roche Revenue in Biopharmaceuticals Business (2018-2023) & (US$ Million)

Table 56. Roche Recent Development

Table 57. Amgen Company Detail

Table 58. Amgen Business Overview

Table 59. Amgen Biopharmaceuticals Product

Table 60. Amgen Revenue in Biopharmaceuticals Business (2018-2023) & (US$ Million)

Table 61. Amgen Recent Development

Table 62. AbbVie Company Detail

Table 63. AbbVie Business Overview

Table 64. AbbVie Biopharmaceuticals Product

Table 65. AbbVie Revenue in Biopharmaceuticals Business (2018-2023) & (US$ Million)

Table 66. AbbVie Recent Development

Table 67. Sanofi-Aventis Company Detail

Table 68. Sanofi-Aventis Business Overview

Table 69. Sanofi-Aventis Biopharmaceuticals Product

Table 70. Sanofi-Aventis Revenue in Biopharmaceuticals Business (2018-2023) & (US$ Million)

Table 71. Sanofi-Aventis Recent Development

Table 72. Johnson & Johnson Company Detail

Table 73. Johnson & Johnson Business Overview

Table 74. Johnson & Johnson Biopharmaceuticals Product

Table 75. Johnson & Johnson Revenue in Biopharmaceuticals Business (2018-2023) & (US$ Million)

Table 76. Johnson & Johnson Recent Development

Table 77. Pfizer Company Detail

Table 78. Pfizer Business Overview

Table 79. Pfizer Biopharmaceuticals Product

Table 80. Pfizer Revenue in Biopharmaceuticals Business (2018-2023) & (US$ Million)

Table 81. Pfizer Recent Development

Table 82. Novo Nordisk Company Detail

Table 83. Novo Nordisk Business Overview

Table 84. Novo Nordisk Biopharmaceuticals Product

Table 85. Novo Nordisk Revenue in Biopharmaceuticals Business (2018-2023) & (US$ Million)

Table 86. Novo Nordisk Recent Development

Table 87. Eli Lilly Company Detail

Table 88. Eli Lilly Business Overview

Table 89. Eli Lilly Biopharmaceuticals Product

Table 90. Eli Lilly Revenue in Biopharmaceuticals Business (2018-2023) & (US$ Million)

Table 91. Eli Lilly Recent Development

Table 92. Novartis Company Detail

Table 93. Novartis Business Overview

Table 94. Novartis Biopharmaceuticals Product

Table 95. Novartis Revenue in Biopharmaceuticals Business (2018-2023) & (US$ Million)

Table 96. Novartis Recent Development

Table 97. Merck Company Detail

Table 98. Merck Business Overview

Table 99. Merck Biopharmaceuticals Product

Table 100. Merck Revenue in Biopharmaceuticals Business (2018-2023) & (US$ Million)

Table 101. Merck Recent Development

Table 102. Sun Company Detail

Table 103. Sun Business Overview

Table 104. Sun Biopharmaceuticals Product

Table 105. Sun Revenue in Biopharmaceuticals Business (2018-2023) & (US$ Million)

Table 106. Sun Recent Development

Table 107. 3sbio Company Detail

Table 108. 3sbio Business Overview

Table 109. 3sbio Biopharmaceuticals Product

Table 110. 3sbio Revenue in Biopharmaceuticals Business (2018-2023) & (US$ Million)

Table 111. 3sbio Recent Development

Table 112. Changchun High Tech Company Detail

Table 113. Changchun High Tech Business Overview

Table 114. Changchun High Tech Biopharmaceuticals Product

Table 115. Changchun High Tech Revenue in Biopharmaceuticals Business (2018-2023) & (US$ Million)

Table 116. Changchun High Tech Recent Development

Table 117. CP Guojian Company Detail

Table 118. CP Guojian Business Overview

Table 119. CP Guojian Biopharmaceuticals Product

Table 120. CP Guojian Revenue in Biopharmaceuticals Business (2018-2023) & (US$ Million)

Table 121. CP Guojian Recent Development

Table 122. Biotech Company Detail

Table 123. Biotech Business Overview

Table 124. Biotech Biopharmaceuticals Product

Table 125. Biotech Revenue in Biopharmaceuticals Business (2018-2023) & (US$ Million)

Table 126. Biotech Recent Development

Table 127. Gelgen Company Detail

Table 128. Gelgen Business Overview

Table 129. Gelgen Biopharmaceuticals Product

Table 130. Gelgen Revenue in Biopharmaceuticals Business (2018-2023) & (US$ Million)

Table 131. Gelgen Recent Development

Table 132. Innovent Company Detail

Table 133. Innovent Business Overview

Table 134. Innovent Biopharmaceuticals Product

Table 135. Innovent Revenue in Biopharmaceuticals Business (2018-2023) & (US$ Million)

Table 136. Innovent Recent Development

Table 137. Dong Bao Company Detail

Table 138. Dong Bao Business Overview

Table 139. Dong Bao Biopharmaceuticals Product

Table 140. Dong Bao Revenue in Biopharmaceuticals Business (2018-2023) & (US$ Million)

Table 141. Dong Bao Recent Development

Table 142. Ganlee Company Detail

Table 143. Ganlee Business Overview

Table 144. Ganlee Biopharmaceuticals Product

Table 145. Ganlee Revenue in Biopharmaceuticals Business (2018-2023) & (US$ Million)

Table 146. Ganlee Recent Development

Table 147. United Laboratories Company Detail

Table 148. United Laboratories Business Overview

Table 149. United Laboratories Biopharmaceuticals Product

Table 150. United Laboratories Revenue in Biopharmaceuticals Business (2018-2023) & (US$ Million)

Table 151. United Laboratories Recent Development

Table 152. SANDOZ (NOVARTIS) Company Detail

Table 153. SANDOZ (NOVARTIS) Business Overview

Table 154. SANDOZ (NOVARTIS) Biopharmaceuticals Product

Table 155. SANDOZ (NOVARTIS) Revenue in Biopharmaceuticals Business (2018-2023) & (US$ Million)

Table 156. SANDOZ (NOVARTIS) Recent Development

Table 157. Teva Pharmaceutical Company Detail

Table 158. Teva Pharmaceutical Business Overview

Table 159. Teva Pharmaceutical Biopharmaceuticals Product

Table 160. Teva Pharmaceutical Revenue in Biopharmaceuticals Business (2018-2023) & (US$ Million)

Table 161. Teva Pharmaceutical Recent Development

Table 162. Hospira （Pfizer） Company Detail

Table 163. Hospira （Pfizer） Business Overview

Table 164. Hospira （Pfizer） Biopharmaceuticals Product

Table 165. Hospira （Pfizer） Revenue in Biopharmaceuticals Business (2018-2023) & (US$ Million)

Table 166. Hospira （Pfizer） Recent Development

Table 167. MYLAN Company Detail

Table 168. MYLAN Business Overview

Table 169. MYLAN Biopharmaceuticals Product

Table 170. MYLAN Revenue in Biopharmaceuticals Business (2018-2023) & (US$ Million)

Table 171. MYLAN Recent Development

Table 172. Sun pharma Company Detail

Table 173. Sun pharma Business Overview

Table 174. Sun pharma Biopharmaceuticals Product

Table 175. Sun pharma Revenue in Biopharmaceuticals Business (2018-2023) & (US$ Million)

Table 176. Sun pharma Recent Development

Table 177. Research Programs/Design for This Report

Table 178. Key Data Information from Secondary Sources

Table 179. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Biopharmaceuticals Market Size Comparison by Type (2023-2029) & (US$ Million)

Figure 2. Global Biopharmaceuticals Market Share by Type: 2022 VS 2029

Figure 3. Monoclonal Antibodies Features

Figure 4. Interferon Features

Figure 5. Colony-Stimulating Factor Features

Figure 6. Erythropoietin Features

Figure 7. Insulin Features

Figure 8. Vaccines Features

Figure 9. Growth Hormones Features

Figure 10. Others Features

Figure 11. Global Biopharmaceuticals Market Size Comparison by Application (2023-2029) & (US$ Million)

Figure 12. Global Biopharmaceuticals Market Share by Application: 2022 VS 2029

Figure 13. Tumor Case Studies

Figure 14. Diabetes Case Studies

Figure 15. Cardiovascular Case Studies

Figure 16. Hemophilia Case Studies

Figure 17. Others Case Studies

Figure 18. Biopharmaceuticals Report Years Considered

Figure 19. Global Biopharmaceuticals Market Size (US$ Million), Year-over-Year: 2018-2029

Figure 20. Global Biopharmaceuticals Market Size, (US$ Million), 2018 VS 2022 VS 2029

Figure 21. Global Biopharmaceuticals Market Share by Region: 2022 VS 2029

Figure 22. Global Biopharmaceuticals Market Share by Players in 2022

Figure 23. Global Top Biopharmaceuticals Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biopharmaceuticals as of 2022)

Figure 24. The Top 10 and 5 Players Market Share by Biopharmaceuticals Revenue in 2022

Figure 25. North America Biopharmaceuticals Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 26. North America Biopharmaceuticals Market Share by Country (2018-2029)

Figure 27. United States Biopharmaceuticals Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 28. Canada Biopharmaceuticals Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 29. Europe Biopharmaceuticals Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 30. Europe Biopharmaceuticals Market Share by Country (2018-2029)

Figure 31. Germany Biopharmaceuticals Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 32. France Biopharmaceuticals Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 33. U.K. Biopharmaceuticals Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 34. Italy Biopharmaceuticals Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 35. Russia Biopharmaceuticals Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 36. Nordic Countries Biopharmaceuticals Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 37. Asia-Pacific Biopharmaceuticals Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 38. Asia-Pacific Biopharmaceuticals Market Share by Region (2018-2029)

Figure 39. China Biopharmaceuticals Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 40. Japan Biopharmaceuticals Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 41. South Korea Biopharmaceuticals Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 42. Southeast Asia Biopharmaceuticals Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 43. India Biopharmaceuticals Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 44. Australia Biopharmaceuticals Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 45. Latin America Biopharmaceuticals Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 46. Latin America Biopharmaceuticals Market Share by Country (2018-2029)

Figure 47. Mexico Biopharmaceuticals Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 48. Brazil Biopharmaceuticals Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 49. Middle East & Africa Biopharmaceuticals Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 50. Middle East & Africa Biopharmaceuticals Market Share by Country (2018-2029)

Figure 51. Turkey Biopharmaceuticals Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 52. Saudi Arabia Biopharmaceuticals Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 53. Roche Revenue Growth Rate in Biopharmaceuticals Business (2018-2023)

Figure 54. Amgen Revenue Growth Rate in Biopharmaceuticals Business (2018-2023)

Figure 55. AbbVie Revenue Growth Rate in Biopharmaceuticals Business (2018-2023)

Figure 56. Sanofi-Aventis Revenue Growth Rate in Biopharmaceuticals Business (2018-2023)

Figure 57. Johnson & Johnson Revenue Growth Rate in Biopharmaceuticals Business (2018-2023)

Figure 58. Pfizer Revenue Growth Rate in Biopharmaceuticals Business (2018-2023)

Figure 59. Novo Nordisk Revenue Growth Rate in Biopharmaceuticals Business (2018-2023)

Figure 60. Eli Lilly Revenue Growth Rate in Biopharmaceuticals Business (2018-2023)

Figure 61. Novartis Revenue Growth Rate in Biopharmaceuticals Business (2018-2023)

Figure 62. Merck Revenue Growth Rate in Biopharmaceuticals Business (2018-2023)

Figure 63. Sun Revenue Growth Rate in Biopharmaceuticals Business (2018-2023)

Figure 64. 3sbio Revenue Growth Rate in Biopharmaceuticals Business (2018-2023)

Figure 65. Changchun High Tech Revenue Growth Rate in Biopharmaceuticals Business (2018-2023)

Figure 66. CP Guojian Revenue Growth Rate in Biopharmaceuticals Business (2018-2023)

Figure 67. Biotech Revenue Growth Rate in Biopharmaceuticals Business (2018-2023)

Figure 68. Gelgen Revenue Growth Rate in Biopharmaceuticals Business (2018-2023)

Figure 69. Innovent Revenue Growth Rate in Biopharmaceuticals Business (2018-2023)

Figure 70. Dong Bao Revenue Growth Rate in Biopharmaceuticals Business (2018-2023)

Figure 71. Ganlee Revenue Growth Rate in Biopharmaceuticals Business (2018-2023)

Figure 72. United Laboratories Revenue Growth Rate in Biopharmaceuticals Business (2018-2023)

Figure 73. SANDOZ (NOVARTIS) Revenue Growth Rate in Biopharmaceuticals Business (2018-2023)

Figure 74. Teva Pharmaceutical Revenue Growth Rate in Biopharmaceuticals Business (2018-2023)

Figure 75. Hospira （Pfizer） Revenue Growth Rate in Biopharmaceuticals Business (2018-2023)

Figure 76. MYLAN Revenue Growth Rate in Biopharmaceuticals Business (2018-2023)

Figure 77. Sun pharma Revenue Growth Rate in Biopharmaceuticals Business (2018-2023)

Figure 78. Bottom-up and Top-down Approaches for This Report

Figure 79. Data Triangulation

Figure 80. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

Global Biopharmaceuticals Market Research Report 2023

Published Date: January 2023

Report Code: QYRE-Auto-30B2315

Global Biopharmaceuticals Market Research Report 2023

FEATURED COMPANIES

BY COMPANY

Segment by Type

Segment by Application

BY REGION

FEATURED COMPANIES

RELATED REPORTS